John Hussman's AUPH Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 105,000 shares of Aurinia Pharmaceuticals Inc. (AUPH) worth $1.67 M, representing 0.40% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, John Hussman has maintained this position in AUPH for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 147,000 shares. Largest reduction occurred in Q3 2025, reducing 231,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Aurinia Pharmaceuticals (AUPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aurinia Pharmaceuticals (AUPH) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -21,000 | Reduce 16.67% | 105,000 | $15.95 |
| Q3 2025 | -231,000 | Reduce 64.71% | 126,000 | $11.05 |
| Q2 2025 | +147,000 | Add 70.00% | 357,000 | $8.47 |
| Q1 2025 | +210,000 | New Buy | 210,000 | $8.04 |
John Hussman's Aurinia Pharmaceuticals Investment FAQs
John Hussman first purchased Aurinia Pharmaceuticals Inc. (AUPH) in Q1 2025, acquiring 210,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Aurinia Pharmaceuticals Inc. (AUPH) for 4 quarters since Q1 2025.
John Hussman's largest addition to Aurinia Pharmaceuticals Inc. (AUPH) was in Q1 2025, adding 210,000 shares worth $1.69 M.
According to the latest 13F filing for Q4 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 105,000 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $1.67 M.
As of the Q4 2025 filing, Aurinia Pharmaceuticals Inc. (AUPH) represents approximately 0.40% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Aurinia Pharmaceuticals Inc. (AUPH) was 357,000 shares, as reported at the end of Q2 2025.